Literature DB >> 17475687

Longitudinal study of herpes simplex virus type 2 infection using viral dynamic modelling.

Catherine M Crespi1, William G Cumberland, Anna Wald, Lawrence Corey, Sally Blower.   

Abstract

OBJECTIVES: Rates of reactivation of herpes simplex virus type 2 (HSV-2) change over time and these changes affect transmission and clinical management strategies. We conducted a longitudinal study of HSV-2 infection to quantify rates of change in HSV-2 reactivation, mucosal shedding and recurrences of genital lesions, using a newly available model of HSV within-host dynamics.
METHODS: A cohort of 18 women was studied at two time periods spaced 2 years apart. The cohort provided daily mucosal swabs for HSV PCR analysis for 10 weeks during each time period and recorded recurrences in diaries. We fit the model of HSV dynamics to the mucosal shedding data using Bayesian methods to produce estimates of HSV reactivation, shedding and longitudinal rates of change. The model was validated using a separate group of 67 individuals.
RESULTS: According to the viral dynamic modelling results, rates of HSV-2 reactivation from latency in the ganglia varied >10-fold among the women, and were estimated to be > or = 10% higher than rates of mucosal shedding episodes for many individuals. The mucosal shedding associated with each reactivation typically lasted 1-3 days. Reactivation frequency was estimated to be declining by three reactivations a year on average. The median number of recurrences, based on patient diaries, declined from 6.8 per year to 2.1 per year over the 2-year period.
CONCLUSIONS: Rates of HSV-2 reactivation, shedding and recurrence generally decline over time but remain high in some individuals 4-5 years after primary infection. Viral dynamic modelling provides quantification of HSV infection that cannot be obtained by other methods.

Entities:  

Mesh:

Year:  2007        PMID: 17475687      PMCID: PMC2659025          DOI: 10.1136/sti.2006.022020

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  8 in total

1.  Targeting virological core groups: a new paradigm for controlling herpes simplex virus type 2 epidemics.

Authors:  Sally Blower; Anna Wald; Hayley Gershengorn; Fei Wang; Larry Corey
Journal:  J Infect Dis       Date:  2004-09-30       Impact factor: 5.226

2.  A queueing model for chronic recurrent conditions under panel observation.

Authors:  Catherine M Crespi; William G Cumberland; Sally Blower
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

3.  Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.

Authors:  A Wald; L Corey; R Cone; A Hobson; G Davis; J Zeh
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

4.  Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture.

Authors:  Anna Wald; Meei-Li Huang; David Carrell; Stacy Selke; Lawrence Corey
Journal:  J Infect Dis       Date:  2003-10-31       Impact factor: 5.226

5.  Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir.

Authors:  A Wald; J Zeh; G Barnum; L G Davis; L Corey
Journal:  Ann Intern Med       Date:  1996-01-01       Impact factor: 25.391

6.  Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.

Authors:  Rachna Gupta; Anna Wald; Elizabeth Krantz; Stacy Selke; Terri Warren; Mauricio Vargas-Cortes; Gerri Miller; Lawrence Corey
Journal:  J Infect Dis       Date:  2004-09-20       Impact factor: 5.226

7.  Genital shedding of herpes simplex virus among men.

Authors:  Anna Wald; Judith Zeh; Stacy Selke; Terri Warren; Rhoda Ashley; Lawrence Corey
Journal:  J Infect Dis       Date:  2002-10-15       Impact factor: 5.226

Review 8.  Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review.

Authors:  Jennifer S Smith; N Jamie Robinson
Journal:  J Infect Dis       Date:  2002-10-15       Impact factor: 5.226

  8 in total
  20 in total

1.  Preventing sexually transmitted infections: back to basics.

Authors:  Anne Rompalo
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

2.  Viral kinetics of genital herpes: a molecular probe into host-viral interactions.

Authors:  Thomas C Quinn
Journal:  J Infect Dis       Date:  2011-08-15       Impact factor: 5.226

Review 3.  HSV-2: in pursuit of a vaccine.

Authors:  Christine Johnston; David M Koelle; Anna Wald
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

4.  In vivo disruption of latent HSV by designer endonuclease therapy.

Authors:  Martine Aubert; Emily A Madden; Michelle Loprieno; Harshana S DeSilva Feelixge; Laurence Stensland; Meei-Li Huang; Alexander L Greninger; Pavitra Roychoudhury; Nixon Niyonzima; Thuy Nguyen; Amalia Magaret; Roman Galleto; Daniel Stone; Keith R Jerome
Journal:  JCI Insight       Date:  2016-09-08

Review 5.  Mucosal treatments for herpes simplex virus: insights on targeted immunoprophylaxis and therapy.

Authors:  Chris L McGowin; Richard B Pyles
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

6.  Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection.

Authors:  Christine Johnston; Jia Zhu; Lichen Jing; Kerry J Laing; Christopher M McClurkan; Alexis Klock; Kurt Diem; Lei Jin; Jeffrey Stanaway; Elizabeth Tronstein; William W Kwok; Meei-Li Huang; Stacy Selke; Youyi Fong; Amalia Magaret; David M Koelle; Anna Wald; Lawrence Corey
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

7.  Overlapping reactivations of herpes simplex virus type 2 in the genital and perianal mucosa.

Authors:  Sunitha Tata; Christine Johnston; Meei-Li Huang; Stacy Selke; Amalia Magaret; Lawrence Corey; Anna Wald
Journal:  J Infect Dis       Date:  2010-02-15       Impact factor: 5.226

Review 8.  Use of the designation "shedder" in mucosal detection of herpes simplex virus DNA involving repeated sampling.

Authors:  A S Magaret; C Johnston; A Wald
Journal:  Sex Transm Infect       Date:  2009-02-11       Impact factor: 3.519

9.  Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults.

Authors:  Karen E Mark; Anna Wald; Amalia S Magaret; Stacy Selke; Laura Olin; Meei-Li Huang; Lawrence Corey
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

10.  CD8 T cell control of HSV reactivation from latency is abrogated by viral inhibition of MHC class I.

Authors:  Mark T Orr; Meredith A Mathis; Michael Lagunoff; Jilian A Sacks; Christopher B Wilson
Journal:  Cell Host Microbe       Date:  2007-09-13       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.